Press Releases

October 21, 2020

ProMIS Neurosciences’ perspective on aducanumab advancement: is approval likely?

October 13, 2020

ProMIS Neurosciences’ Neil Cashman to Speak at Protein Misfolding Drug Discovery Conference 

Press Archives

In the News

September 23, 2020

Pharma Boardroom – Aducanumab: On the Regulatory Home Stretch in the USA

September 8, 2020

Neurology Live – Aducanumab’s Unlikely Road to the FDA: Is Approval Imminent?

News Archives

Podcasts

Presentations

January 27, 2020

Sachs Neuroscience Innovation Forum Presentation

November 6, 2019

ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platform

Presentations Archives

Videos

November 6, 2019

ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platform

August 6, 2019

Dr. James Kupiec’s update from AAIC 2019: Demonstrating Early Proof-of-Concept with Biomarkers and Focused Patient Populations

July 18, 2019

ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019 

Video Archives